In adults with diabetic urinary incontinence, non-diabetic incontinence and controls, serum LL‑37 showed no Bonferroni-corrected pairwise differences.
In plain wordsNatural LL‑37 levels in blood did not differ between adults with diabetic incontinence, other incontinence and healthy controls.
- Peptide
- LL-37
- Outcome
- No significant changeSerum LL-37 across diabetic incontinence, non-diabetic incontinence and controls
- Study
n = 120
- Outcome group
- Inflammation markers · Kidney and urinary
Source sentences
LL-37, elafin, VDR, and Aβ1-42 showed no Bonferroni-corrected pairwise differences.
1 context sentence(design, population, supporting numbers)
We conducted a cross-sectional, single-centre observational study including 120 adults: type II diabetes with urinary incontinence (DI; n = 40), non-diabetic urinary incontinence (Non-DI; n = 40), and healthy controls (n = 40).
This result measures the body's own LL-37. Nobody was given the peptide. It is not evidence about taking it.